Biological
Hematopoietic stem cell transplant (HSCT)
Hematopoietic stem cell transplant (HSCT) is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
100%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
2
50%
Ph phase_1
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
terminated125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
NCT07284641
completedphase_1
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
NCT00429143
terminatedphase_2
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
NCT01532635
completedphase_1
Hematopoietic Stem Cell Transplant for Sickle Cell Disease
NCT02065596
Clinical Trials (4)
Showing 4 of 4 trials
NCT07284641Phase 2
Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)
NCT00429143Phase 1
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
NCT01532635Phase 2
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
NCT02065596Phase 1
Hematopoietic Stem Cell Transplant for Sickle Cell Disease
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4